Satellos Bioscience Files 6-K Report
Ticker: MSLE · Form: 6-K · Filed: Mar 27, 2026 · CIK: 0001421642
| Field | Detail |
|---|---|
| Company | Satellos Bioscience INC. (MSLE) |
| Form Type | 6-K |
| Filed Date | Mar 27, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
Satellos Bioscience filed a 6-K, likely with an update. Details TBD.
AI Summary
Satellos Bioscience Inc. filed a Form 6-K on March 27, 2026. This report includes a press release as an exhibit, but the specific details of the press release, such as financial figures or significant events, are not provided in the filing summary.
Why It Matters
This filing indicates Satellos Bioscience Inc. is providing an update to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 6-K report, which typically contains routine updates and does not inherently signal high risk.
Key Players & Entities
- Satellos Bioscience Inc. (company) — Filer
- 0001421642 (company) — CIK Number
- 2026-03-27 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to provide information that the company has made or is required to make public in its home country, or that it has distributed or made available to its security holders.
What document is included as an exhibit in this filing?
Exhibit EX-99.1, a press release, is included in this filing.
When was this Form 6-K filed and accepted by the SEC?
The filing date and acceptance date for this Form 6-K was March 27, 2026.
What is the CIK number for Satellos Bioscience Inc.?
The CIK number for Satellos Bioscience Inc. is 0001421642.
What is the business address of Satellos Bioscience Inc.?
The business address of Satellos Bioscience Inc. is ROYAL BANK PLAZA, S. TOWER, 200 BAY ST. SUITE 2800 TORONTO A6 M5J 2J1.
Filing Stats: 170 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2026-03-27 07:00:06
Filing Documents
- f6k_032726.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 16KB
- 0001171843-26-001965.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SATELLOS BIOSCIENCE INC. (Registrant) Date: March 27, 2026 /s/ Elizabeth Williams, CPA, CA Elizabeth Williams, CPA, CA Chief Financial Officer